Evidence map›Paper›PMID 38932897›Full record

ArticleJournal of diabetes and metabolic disorders2024

Development of type 2 diabetes risk assessment model for Turkish society.

Şirin Çelikkanat, Zeynep Güngörmüş, Özlem Akay

Abstract read
In one paragraph

Article in Journal of diabetes and metabolic disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Şirin ÇelikkanatGaziantep Islam Science and Technology, Department of Nursing, University of Health Sciences, Gaziantep, Turkey.ORCID 0000-0001-9475-4505
Zeynep GüngörmüşGaziantep Islam Science and Technology, Department of Nursing, University of Health Sciences, Gaziantep, Turkey.ORCID 0000-0002-3761-8184
Özlem AkayGaziantep Islam Science and Technology University Medical School Department, Gaziantep, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The study was conducted to develop a risk assessment tool to determine the Turkish population's risk of undiagnosed type 2 diabetes. Methods: The study was carried out in a methodological design. A total of 610 individuals, including those diagnosed with diabetes (321) and not diagnosed with diabetes (289), who applied to the internal medicine and diabetes outpatient clinics of a public hospital, were included in the study. The sample of patients with diabetes was created with the individuals who applied to diabetes outpatient clinics, were 40 years of age and older, and had the values of FPG ≥ 126 mg/dl and HbA1C ≥ 6.5%. The sample of healthy individuals consisted of people over the age of 40 who were not diagnosed with diabetes or prediabetes. Logistic regression and random forest algorithms were used to evaluate the diabetes risk of individuals. The performance of the models was evaluated with sensitivity, specificity, accuracy, and area under the ROC (AUC). Result: In the study, the variables of exercise in daily routines, presence of prediabetes, getting angry, feeling hungry frequently, and excessive thirst formed the diabetes risk assessment model with Sensitivity 0.983 and Specificity 0.984 according to the logistic regression model obtained. Body mass index, physical activity, age, gender, and family history of diabetes were not found to be significant in differentiating cases with diabetes (0.05 < p). Conclusion: This diabetes risk assessment tool is a reliable tool for Turkish society to identify individuals at high risk for diabetes and to raise awareness of the importance of modifiable risk factors.

Indexed as

DiabetesRisk assessment toolTurkish population

Identifiers

PMID38932897
PMCPMC11196534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.